ChemicalBook >> CAS DataBase List >>7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one

CAS No.
4425-23-4
Chemical Name:
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one
Synonyms
RLX;PD-139530;2,3-Pentanoquinazoline-4(3H)-one;VASICINONE HCl (Deoxydihomo-'c'-);7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one;6,7,8,9,10,12-Hexahydroazepino[2,1-b]quinazoline-12-one;Azepino[2,1-b]quinazolin-12(6H)-one, 7,8,9,10-tetrahydro-
CBNumber:
CB31339212
Molecular Formula:
C13H14N2O
Molecular Weight:
214.26
MDL Number:
MFCD00661748
MOL File:
4425-23-4.mol
MSDS File:
SDS
Last updated:2026-08-05 19:35:02

SAFETY

Risk and Safety Statements

HS Code  2933998090
Toxicity LD50 oral in mouse: 1250mg/kg

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Biosynth EAA42523 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one 4425-23-4 100mg $250 2026-06-04 Buy
Biosynth EAA42523 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one 4425-23-4 250mg $325 2026-06-04 Buy
Biosynth EAA42523 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one 4425-23-4 500mg $520 2026-06-04 Buy
Biosynth EAA42523 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one 4425-23-4 1000mg $830 2026-06-04 Buy
Biosynth EAA42523 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one 4425-23-4 5000mg $2700 2026-06-04 Buy
Product number Packaging Price Buy
EAA42523 100mg $250 Buy
EAA42523 250mg $325 Buy
EAA42523 500mg $520 Buy
EAA42523 1000mg $830 Buy
EAA42523 5000mg $2700 Buy

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Chemical Properties, Uses, Production

Uses

RLX (PD 139530) is a PI3K/Akt/FoxO3a signaling inhibitor, possessing significant therapeutic potential in experimental colon cancer. RLX can effectively modulate the tumor microenvironment, enhancing the efficacy of cancer immunotherapy. RLX demonstrates the ability to improve the retention time of therapeutic agents within the tumor microenvironment by utilizing advanced nanoparticle delivery systems. RLX can be integrated with various treatment modalities, such as chemotherapy and radiotherapy, to enhance overall tumor therapy effectiveness. RLX highlights the necessity for further research into the tumor microenvironment’s dynamics to develop more tailored treatment approaches for diverse tumor types.

References

[1] The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Preparation Products And Raw materials

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Suppliers

Global Suppliers ( 8)
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
Shanghai Amole Biotechnology Co., Ltd. 13370042665 18916960931 2596183085@qq.com China 17234 58
TargetMol Chemicals Inc. 13564774135 marketing@targetmol.com United States 19950 58

View Latest Price from 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
RLX pictures 2026-08-04 RLX
4425-23-4
$1520.00-2500.00 99.81% 10g TargetMol Chemicals Inc.
  • RLX pictures
  • RLX
    4425-23-4
  • $1520.00-2500.00
  • 99.81%
  • TargetMol Chemicals Inc.

7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Spectrum

2,3-Pentanoquinazoline-4(3H)-one 6,7,8,9,10,12-Hexahydroazepino[2,1-b]quinazoline-12-one PD-139530 RLX VASICINONE HCl (Deoxydihomo-'c'-) 7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one Azepino[2,1-b]quinazolin-12(6H)-one, 7,8,9,10-tetrahydro- 4425-23-4